• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

人乳腺癌中肿瘤浸润淋巴细胞与癌相关T(汤姆森-弗里德赖希)/Tn抗原的同步免疫组织化学染色

Concurrent immunohistochemical staining of tumor-infiltrating lymphocytes and carcinoma-associated T (Thomsen-Friedenreich)/Tn antigens in human breast carcinoma.

作者信息

Wang B L, Springer G F, Kaufman M W

机构信息

Heather M. Bligh Cancer Research Laboratories, Chicago Medical School, IL 60064, USA.

出版信息

J Histochem Cytochem. 1996 Feb;44(2):187-91. doi: 10.1177/44.2.8609376.

DOI:10.1177/44.2.8609376
PMID:8609376
Abstract

The composition of tumor-infiltrating lymphocytes (TIL) often reflects the host's immune response to the tumor. To study the relationship of TIL and carcinoma-associated T/Tn antigens in breast carcinoma, a straightforward concurrent immunoenzyme staining procedure was developed. Fresh tissue was directly fixed in a zinc-based fixative to preserve lymphocyte markers and then routinely embedded in paraffin. The TIL subtypes in the sections were identified in the first immunostaining cycle by reaction with a monoclonal antibody (MAb) to lymphocyte markers CD3, CD4, CD8, CD19, or CD56, followed by a modified avidin-biotin procedure and diaminobenzidine tetrahydrochloride-H2O2 for color development. This was followed by paraformaldehyde fixation to block antibody crossreactivity. The T and Tn antigens on carcinoma cells were then demonstrated in a second staining cycle by reaction with an MAb against T or Tn antigen, followed by an indirect immunoalkaline phosphatase procedure and corresponding substrate systems for color development. The distinguishable brown color for TIL and blue or red color for T or Tn antigen enabled us to identify the TIL subsets and to describe their relations with T/Tn antigen expression in situ. This approach may contribute to better understanding of the patients' immune defenses against their tumor and aid in prognostication.

摘要

肿瘤浸润淋巴细胞(TIL)的组成常常反映宿主对肿瘤的免疫反应。为了研究乳腺癌中TIL与癌相关T/Tn抗原的关系,开发了一种直接的同步免疫酶染色方法。新鲜组织直接固定于锌基固定剂中以保存淋巴细胞标志物,然后常规石蜡包埋。在第一个免疫染色循环中,通过与针对淋巴细胞标志物CD3、CD4、CD8、CD19或CD56的单克隆抗体(MAb)反应来识别切片中的TIL亚型,随后采用改良的抗生物素蛋白-生物素方法和四盐酸二氨基联苯胺-H2O2进行显色。接着用多聚甲醛固定以阻断抗体交叉反应。然后在第二个染色循环中,通过与抗T或Tn抗原的MAb反应来显示癌细胞上的T和Tn抗原,随后采用间接免疫碱性磷酸酶方法和相应的底物系统进行显色。TIL呈现可区分的棕色,T或Tn抗原呈现蓝色或红色,这使我们能够原位识别TIL亚群并描述它们与T/Tn抗原表达的关系。这种方法可能有助于更好地理解患者针对肿瘤的免疫防御,并有助于预后判断。

相似文献

1
Concurrent immunohistochemical staining of tumor-infiltrating lymphocytes and carcinoma-associated T (Thomsen-Friedenreich)/Tn antigens in human breast carcinoma.人乳腺癌中肿瘤浸润淋巴细胞与癌相关T(汤姆森-弗里德赖希)/Tn抗原的同步免疫组织化学染色
J Histochem Cytochem. 1996 Feb;44(2):187-91. doi: 10.1177/44.2.8609376.
2
Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer.人乳腺癌肿瘤浸润淋巴细胞的表型分析
Anticancer Res. 1992 Sep-Oct;12(5):1463-6.
3
Phenotype, cytokine production and cytolytic capacity of fresh (uncultured) tumour-infiltrating T lymphocytes in human renal cell carcinoma.人肾细胞癌中新鲜(未培养)肿瘤浸润性T淋巴细胞的表型、细胞因子产生及细胞溶解能力
Clin Exp Immunol. 1997 Sep;109(3):501-9. doi: 10.1046/j.1365-2249.1997.4771375.x.
4
CD3+, CD4+ & CD8+ tumour infiltrating lymphocytes (TILs) are predictors of favourable survival outcome in infiltrating ductal carcinoma of breast.CD3 +、CD4 +和CD8 +肿瘤浸润淋巴细胞(TILs)是乳腺浸润性导管癌生存预后良好的预测指标。
Indian J Med Res. 2014 Sep;140(3):361-9.
5
Characterization of fresh (uncultured) tumour-infiltrating lymphocytes (TIL) and TIL-derived T cell lines from patients with renal cell carcinoma.肾细胞癌患者新鲜(未培养)肿瘤浸润淋巴细胞(TIL)及TIL衍生T细胞系的特征分析
Clin Exp Immunol. 1994 Aug;97(2):321-7. doi: 10.1111/j.1365-2249.1994.tb06088.x.
6
Morphological Evaluation of Tumor-Infiltrating Lymphocytes (TILs) to Investigate Invasive Breast Cancer Immunogenicity, Reveal Lymphocytic Networks and Help Relapse Prediction: A Retrospective Study.肿瘤浸润淋巴细胞(TILs)的形态学评估以研究浸润性乳腺癌的免疫原性、揭示淋巴细胞网络并辅助复发预测:一项回顾性研究
Int J Mol Sci. 2017 Sep 8;18(9):1936. doi: 10.3390/ijms18091936.
7
Immunohistochemical expression of T, Tn and sialyl-Tn antigens and clinical outcome in human breast carcinoma.人乳腺癌中T、Tn和唾液酸化-Tn抗原的免疫组化表达及临床结局
Anticancer Res. 2001 Mar-Apr;21(2B):1327-34.
8
Differential expression of the cancer associated antigens T (Thomsen-Friedenreich) and Tn to the skin in primary and metastatic carcinomas.癌症相关抗原T(汤姆森-弗里德赖希抗原)和Tn在原发性及转移性癌中与皮肤的差异表达。
J Clin Pathol. 1998 Aug;51(8):588-92. doi: 10.1136/jcp.51.8.588.
9
Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.与子宫颈癌患者肿瘤引流淋巴结及外周血中的淋巴细胞相比,肿瘤浸润淋巴细胞含有更多数量的1型细胞因子表达细胞和DR+T细胞。
Gynecol Oncol. 2001 Jun;81(3):424-32. doi: 10.1006/gyno.2001.6200.
10
Changes of tumor infiltrating lymphocyte subtypes before and after neoadjuvant endocrine therapy in estrogen receptor-positive breast cancer patients--an immunohistochemical study of Cd8+ and Foxp3+ using double immunostaining with correlation to the pathobiological response of the patients.在接受新辅助内分泌治疗的雌激素受体阳性乳腺癌患者中,肿瘤浸润淋巴细胞亚群的变化——采用 CD8+和 Foxp3+双重免疫组化染色的免疫组织化学研究及其与患者病理生物学反应的相关性。
Int J Biol Markers. 2012 Dec 27;27(4):e295-304. doi: 10.5301/JBM.2012.10439.

引用本文的文献

1
Inflammation and breast cancer. Balancing immune response: crosstalk between adaptive and innate immune cells during breast cancer progression.炎症与乳腺癌。平衡免疫反应:乳腺癌进展过程中适应性免疫细胞与先天性免疫细胞之间的相互作用
Breast Cancer Res. 2007;9(4):212. doi: 10.1186/bcr1746.
2
Naturally occurring B-cell responses to breast cancer.对乳腺癌的天然B细胞反应。
Cancer Immunol Immunother. 2003 Dec;52(12):715-38. doi: 10.1007/s00262-003-0409-4. Epub 2003 Aug 15.